Led · Series B · Apr 2024

AccessHope provides a cancer benefit that shares expert discoveries in cancer care with employees’ health plans and local oncologists to help develop precise treatment plans. The company offers the benefit to roughly seven million members through more than 400 employer customers, including over 60 Fortune 500 companies. Through its foundational partnerships, members have access to expertise from more than 350 oncologists covering all cancer types and stages. Foundational partners include City of Hope, Dana‑Farber Cancer Institute, Emory Healthcare and Winship Cancer Institute of Emory University, Fred Hutch Cancer Center, Johns Hopkins Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. AccessHope is led by CEO Bradley Kreick and is based in Duarte, CA. The company plans ongoing product and technology development, oncology network expansion, and expansion into new markets such as health plans, Medicare, and government organizations.

Participated · Series A · Jan 2022

Reimagine Care delivers virtual-first, home-centered cancer care by combining clinical oncology experts with an easy-to-use technology platform to provide high-touch, individualized treatment and recovery experiences. The company emphasizes patient-centric, accessible, coordinated, and affordable oncology care designed to keep patients comfortable at home. Its model pairs empathetic clinical teams with data-driven tools to personalize care and improve the patient experience. Reimagine Care works with leading clinical institutions to integrate care delivery and value-based approaches. The company announced an investment from Oncology Ventures to support product development and commercial acceleration of its platform. Founded in 2020 and based in Nashville, Tenn., Reimagine Care delivers virtual and at-home cancer care by integrating clinical oncology specialists with technology, data and analytics. The company acts as an extension of patients' oncology teams to provide safe, coordinated care from the home and offers 24/7 access to experienced oncology clinicians. Its platform includes a Virtual Care Center for around-the-clock symptom management and leverages advanced data analytics and AI to personalize treatment and management. According to Reimagine Care's 2023 consumer research, 82% of patients would like to receive care at home and over 90% want on-demand access to an oncology expert; patients rate the service 9.1 out of 10. The Virtual Care Center reports a 95% success rate in keeping patients out of emergency rooms. Reimagine Care intends to accelerate development and deployment of its technologies to expand home-centered cancer treatment and recovery. Reimagine Care partners with providers and health plans to coordinate oncology care in the home, aiming to avoid unnecessary inpatient visits. Its clinicians remotely monitor patients, collaborate with oncologists to assess needs, and can dispatch home care workers when required. The company plans to use its recent funding to improve and commercialize its tech-enabled services platform, launch a virtual care center, and expand its care team. Reimagine says the approach is designed to improve patient experience, increase profitability for health systems, and differentiate providers. The company recently raised $25 million in a Series A round to support these initiatives. The market backdrop includes a large telehealth expansion during the COVID-19 pandemic, with Medicare telehealth visits rising from about 840,000 in 2019 to 52.7 million in 2020 per an HHS report.